Journal
HEALTH AFFAIRS
Volume 24, Issue 3, Pages 622-630Publisher
PROJECT HOPE
DOI: 10.1377/hlthaff.24.3.622
Keywords
-
Ask authors/readers for more resources
During the past fifty years, the number of pharmaceutical companies making vaccines has decreased dramatically, and those that still make vaccines have reduced resources to make new ones. Pharmaceutical companies are gradually abandoning vaccines because the research, development, testing, and manufacture of vaccines are expensive and because the market to sell vaccines is much smaller than the market for other drug products. Congressional action could assure both a steady supply of existing vaccines and the promise of vaccines for the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available